- Home
- FGEN vs ANGH Comparison
FGEN vs ANGH Comparison
Compare FGEN & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- ANGH
- Stock Information
- Founded
- FGEN 1993
- ANGH 2012
- Country
- FGEN United States
- ANGH United Arab Emirates
- Employees
- FGEN N/A
- ANGH N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- ANGH Telecommunications Equipment
- Sector
- FGEN Health Care
- ANGH Consumer Discretionary
- Exchange
- FGEN Nasdaq
- ANGH Nasdaq
- Market Cap
- FGEN 33.5M
- ANGH 32.1M
- IPO Year
- FGEN 2014
- ANGH N/A
- Fundamental
- Price
- FGEN $5.85
- ANGH $0.50
- Analyst Decision
- FGEN Strong Buy
- ANGH
- Analyst Count
- FGEN 1
- ANGH 0
- Target Price
- FGEN $250.00
- ANGH N/A
- AVG Volume (30 Days)
- FGEN 61.5K
- ANGH 10.8K
- Earning Date
- FGEN 08-05-2025
- ANGH 07-15-2025
- Dividend Yield
- FGEN N/A
- ANGH N/A
- EPS Growth
- FGEN N/A
- ANGH N/A
- EPS
- FGEN N/A
- ANGH N/A
- Revenue
- FGEN $6,996,000.00
- ANGH $78,093,405.00
- Revenue This Year
- FGEN N/A
- ANGH N/A
- Revenue Next Year
- FGEN N/A
- ANGH N/A
- P/E Ratio
- FGEN N/A
- ANGH N/A
- Revenue Growth
- FGEN N/A
- ANGH 88.72
- 52 Week Low
- FGEN $4.50
- ANGH $0.42
- 52 Week High
- FGEN $38.25
- ANGH $1.08
- Technical
- Relative Strength Index (RSI)
- FGEN 43.29
- ANGH 41.97
- Support Level
- FGEN $5.37
- ANGH $0.47
- Resistance Level
- FGEN $5.73
- ANGH $0.50
- Average True Range (ATR)
- FGEN 0.41
- ANGH 0.02
- MACD
- FGEN 0.07
- ANGH 0.00
- Stochastic Oscillator
- FGEN 77.78
- ANGH 14.29
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.